Podcasts about Biotechnology

Could studying the DNA of extinct animals – or even bringing them back to life – help us save today's endangered species and inform modern medicine?  That may sound like the premise for a Hollywood movie, but it's work that our Raise the Line guest, Dr. Beth Shapiro, is actually engaged in as Chief Science Officer at Colossal Biosciences, which describes itself as the world's first and only de-extinction company.  “It's not just about learning about the past. It's learning about the past so we have more validated scientific information that we can use to predict what we can do to better influence the future,” she tells host Michael Carrese. An internationally-renowned evolutionary molecular biologist and paleogeneticist, Dr. Shapiro is a pioneer in ancient DNA research and has successfully sequenced genomes, like that of the dodo, to study evolution and the impact on humans. At Colossal Biosciences, she leads teams working to bring back traits of extinct species such as the mammoth, not for spectacle, but to restore ecological balance. “When species become extinct, you lose really fundamental interactions between species that existed in that ecosystem. By taking a species that's alive today and editing its DNA so that it resembles those extinct species, we can functionally replace those missing ecological interactions.” Tune into this utterly fascinating conversation to hear about what Jurassic Park got wrong, the positive ecological impact of reintroducing giant tortoises to Mauritius, and the ethics of using gene editing and other biotechnologies. Mentioned in this episode:Colossal Biosciences If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Episode 472 features Dr. Sheila Gujrathi, a biotech entrepreneur, executive, and champion for under represented leaders. Her new book, "The Mirror Effect: A Transformative Approach To Growth For The Next Generation Of Female Leaders" is out now.Chapters:00:00 Introduction and Book Announcement02:15 The Unmet Need: Writing for My Younger Self05:30 Overcoming Challenges: A Personal Journey09:45 The Power of Mentorship and Sponsorship14:00 Spiritual Growth and Finding Purpose18:20 Building a Personal Board of Directors23:10 The Inner Critic and Self-Compassion28:45 The Importance of Storytelling in Leadership33:00 Navigating Negative Work Environments37:15 Conclusion: Embracing Vulnerability and ConnectionFind Sheila Online:Website: ​​https://sheilagujrathimd.com/ TEDxTalk: https://www.youtube.com/watch?v=2DpDx6T3-X4 LinkedIn: https://www.linkedin.com/in/sheila-gujrathi-md/ Instagram: https://www.instagram.com/sheilagujrathimd/ Book: https://sheilagujrathimd.com/book/ About Sheila:Sheila is a biotech entrepreneur, executive, and champion for under represented leaders. Over the past 25 years, she's had the privilege of developing life-changing medicines for patients with serious diseases while building and running private and public biotech companies—including some exciting exits. Today she's a founder, chairwoman, board director, strategic advisor, and consultant to start-up companies and investment funds. Dr. Gujrathi was the co-founder and former CEO of Gossamer Bio and former Chief Medical Officer of Receptos. Her journey started at Northwestern University, where she earned both her M.D. and biomedical engineering degree, and took her from the halls of Harvard, UCSF, and Stanford to the corporate offices of Fortune 500 companies like McKinsey, Genentech, and Bristol-Myers Squibb.Dr. Gujrathi has earned multiple leadership awards, including AIMBE Fellow, BLOC100 Luminary, Healthcare Technology Report Top 25 Women Leaders in Biotechnology, Corporate Directors Forum Director of the Year, and Fiercest Women in Life Sciences. But what really lights her up is creating the inclusive environments she wished she'd had throughout her career. That's why she co-founded the Biotech CEO Sisterhood, a group of trailblazing female CEOs—because we're all better when we support each other.

We've entered a new age. Where nature once took a million years to make a few genetic changes, scientists can now make billions in an afternoon — and even imagine adapting humans for life beyond Earth.George Church, a Harvard geneticist, pioneer of the Human Genome Project, and founder of more than 50 biotech companies, helped lay the foundation for CRISPR, personal genomics, and even de-extinction.In this episode, he explains how biotechnology, AI, and materials science are converging to transform life itself -  from reversing aging and curing disease to resurrecting lost species like the woolly mammoth, and one day, helping humanity thrive among the stars.

Quinzaine de l'Agriculture TinctorialeSavez-vous que la teinture végétale peut transformer non seulement notre façon de colorer les textiles, mais aussi notre rapport à l'agriculture ? Dans cet épisode captivant du podcast ArtEcoVert, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome passionnée par la couleur végétale et les plantes tinctoriales. Elle nous plonge dans le programme riche et varié de la deuxième semaine de la quinzaine de l'agriculture tinctoriale d'ArtEcoVert, qui se déroulera du 17 au 28 novembre. Pauline nous explique les différentes thématiques abordées lors des sessions, mettant en lumière des plantes à jaune comme les coreopsis et le réséda, tout en partageant des retours d'expérience sur les fibres utilisées pour la couleur végétale. Elle souligne l'importance de comprendre les extraits de plantes et nous invite à réfléchir sur la création d'un produit de filière tinctoriale française. En effet, la teinture végétale et les colorants biosourcés sont au cœur de cette démarche respectueuse de l'environnement. Au cours de cet épisode, nous aurons également le plaisir d'écouter des intervenants experts. Cécilia Aguirre nous dévoilera des méthodes de mesure et de valorisation du travail dans les exploitations tinctoriales, tandis que Nils Kieffer nous parlera de la biodiversité apportée par ces plantes fascinantes. Tristan Lienard abordera quant à lui le recyclage de l'eau dans le processus de teinture, un sujet crucial pour les pratiques durables en agriculture tinctoriale. Le programme de cette quinzaine inclut des discussions passionnantes sur les fibres naturelles et les collaborations possibles dans le domaine, offrant aux auditeurs une occasion unique de s'engager dans cette aventure colorée et écologique. En tant que passionnée de teinture végétale, Pauline nous encourage à explorer les nuances et les possibilités infinies qu'offrent les pigments végétaux, tout en ayant un impact positif sur notre santé et notre environnement. Ne manquez pas cette occasion d'en apprendre davantage sur l'art et la science derrière la teinture végétale, ainsi que sur les pratiques soutenables qui façonnent notre avenir. Rejoignez-nous pour découvrir la voix verte de l'agriculture teintoriale et laissez-vous inspirer par les histoires et les expériences partagées. Belle écoute ! ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

Dr. Hemant Kumar Bid is a top educator in the field of Biotechnology and Medical Cannabis, where he uses his extensive background in biotechnology research and cannabinoid research to educate cannabis and biotechnology professionals and infuse the industry with science-backed legitimacy. In addition to serving as a Program Director for the Morehouse School of Medicine and teaching graduate students, Hemant also serves as a Scientific Advisor for Essentia Scientific, a company that delivers an array of cannabinoid product solutions, including acidic cannabinoids, with their patented water-as-solvent extraction technology. During our conversation, we discuss:  What are cannabinoid acids and how do they differ from the neutral cannabinoids  Why have cannabinoid acids been traditionally overlooked in research and consumer products  How THCA produces different effects than THC  Why CBDA is more bioavailable and more potent than CBD  How new extraction and stabilization techniques are helping make cannabinoids acids more accessible  and more  Thanks to This Episode's Sponsor: CANN Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org. Additional Resources Essentia Scientific Website Email Hemant - Hibid@msm.edu Submit Your Abstract for CannMed 26 Meet the CannMed 26 Advisory Board

S4:E194 David covers The Venture Update for the week and then Paul interviews Mike Carnes of the North Carolina Biotechnology Center about recent challenges in dealing with the Foreign Risk constraints for US Biotech Startups that win SBIR Grants. (interview recorded 9.29.25)Follow David and Paul: https://x.com/DGRollingSouth https://x.com/PalmettoAngel Connect On LinkedIn: https://www.linkedin.com/in/davidgrisell/ https://www.linkedin.com/in/paulclarkprivateequity/ We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.

This week on World Ocean Radio we are discussing the September 2025 news that Morocco has become the 60th nation to ratify the High Seas Treaty, a two-decades long process to establish and protect a vast complex of biodiversity in international waters. This is a major milestone and a huge step forward, uniting many rules promoted by many UN agencies under a single rubric and framework for coherent protection. About World Ocean Radio World Ocean Radio is a weekly series of five-minute audio essays available for syndicated use at no cost by college and community radio stations worldwide. Peter Neill, Founder of the World Ocean Observatory and host of World Ocean Radio, provides coverage of a broad spectrum of ocean issues from science and education to advocacy and exemplary projects.World Ocean Radio 15 Years, 760+ Episodes Ocean is climate Climate is ocean The sea connects all thingsWorld Ocean Radio: 5-minute weekly insights in ocean science, advocacy, education, global ocean issues, marine science, policy, challenges, and solutions. Hosted by Peter Neill, Founder of W2O. Learn more at worldoceanobservatory.org

Guests:Dr Colm McKeever, Assistant Lecturer and Researcher in Analytical Chemistry, Department of Pharmaceutical Sciences and Biotechnology, at TUSDr Shelley Brady, DCUDr Laura Hayes, DIAS

In this talk, Sebastian, a bioinformatics researcher and software engineer, shares his inspiring journey from wet lab biotechnology to computational bioinformatics. Hosted by Data Talks Club, this session explores how data science, AI, and open-source tools are transforming modern biological research — from DNA sequencing to metagenomics and protein structure prediction.You'll learn about: - The difference between wet lab and dry lab workflows in biotechnology - How bioinformatics enables faster insights through data-driven modeling - The MCW2 Graph Project and its role in studying wastewater microbiomes - Using co-abundance networks and the CC Lasso algorithm to map microbial interactions - How AlphaFold revolutionized protein structure prediction - Building scientific knowledge graphs to integrate biological metadata - Open-source tools like VueGen and VueCore for automating reports and visualizations - The growing impact of AI and large language models (LLMs) in research and documentation - Key differences between R (BioConductor) and Python ecosystems for bioinformaticsThis talk is ideal for data scientists, bioinformaticians, biotech researchers, and AI enthusiasts who want to understand how data science, AI, and biology intersect. Whether you work in genomics, computational biology, or scientific software, you'll gain insights into real-world tools and workflows shaping the future of bioinformatics.Links:- MicW2Graph: https://zenodo.org/records/12507444- VueGen: https://github.com/Multiomics-Analytics-Group/vuegen- Awesome-Bioinformatics: https://github.com/danielecook/Awesome-BioinformaticsTIMECODES00:00 Sebastian's Journey into Bioinformatics06:02 From Wet Lab to Computational Biology08:23 Wet Lab vs Dry Lab Explained12:35 Bioinformatics as Data Science for Biology15:30 How DNA Sequencing Works19:29 MCW2 Graph and Wastewater Microbiomes23:10 Building Microbial Networks with CC Lasso26:54 Protein–Ligand Simulation Basics29:58 Predicting Protein Folding in 3D33:30 AlphaFold Revolution in Protein Prediction36:45 Inside the MCW2 Knowledge Graph39:54 VueGen: Automating Scientific Reports43:56 VueCore: Visualizing OMIX Data47:50 Using AI and LLMs in Bioinformatics50:25 R vs Python in Bioinformatics Tools53:17 Closing Thoughts from EcuadorConnect with SebastianTwitter - https://twitter.com/sayalaruanoLinkedin - https://linkedin.com/in/sayalaruano Github - https://github.com/sayalaruanoWebsite - https://sayalaruano.github.io/Connect with DataTalks.Club:Join the community - https://datatalks.club/slack.htmlSubscribe to our Google calendar to have all our events in your calendar - https://calendar.google.com/calendar/r?cid=ZjhxaWRqbnEwamhzY3A4ODA5azFlZ2hzNjBAZ3JvdXAuY2FsZW5kYXIuZ29vZ2xlLmNvbQCheck other upcoming events - https://lu.ma/dtc-eventsGitHub: https://github.com/DataTalksClubLinkedIn - https://www.linkedin.com/company/datatalks-club/Twitter - https://twitter.com/DataTalksClub - Website - https://datatalks.club/

An open letter released Wednesday has called for a ban on the development of artificial intelligence systems considered to be “superintelligent” until there is broad scientific consensus that such technologies can be created both safely and in a manner the public supports. The statement, issued by the nonprofit Future of Life Institute, has been signed by more than 700 individuals, including Nobel laureates, technology industry veterans, policymakers, artists, and public figures such as Prince Harry and Meghan Markle, the Duke and Duchess of Sussex. The letter reflects deep and accelerating concerns over projects undertaken by technology giants like Google, OpenAI, and Meta Platforms that are seeking to build artificial intelligence capable of outperforming humans on virtually every cognitive task. According to the letter, such ambitions have raised fears about unemployment due to automation, loss of human control and dignity, national security risks, and the possibility of far-reaching social or existential harms. “We call for a prohibition on the development of superintelligence, not lifted before there is broad scientific consensus that it will be done safely and controllably, and strong public buy-in,” the statement reads. Signatories include AI pioneers Yoshua Bengio and Geoffrey Hinton, both recipients of the Turing Award, Apple co-founder Steve Wozniak, businessman Richard Branson, and actor Joseph Gordon-Levitt. Pentagon personnel could soon be told to participate in new training programs designed to prepare them for anticipated advancements in biotechnology and its convergence with other critical and emerging technologies, like quantum computing and AI. House lawmakers recently passed an amendment en bloc in their version of the fiscal 2026 National Defense Authorization Act that would mandate the secretary of defense to set up such trainings, no later than one year after the legislation's enactment. Biotechnology refers to a multidisciplinary field that involves the application of biological systems or the use of living organisms, like yeast and bacteria, to produce products or solve complex problems. These technologies are expected to revolutionize defense, energy, manufacturing and other sectors globally in the not-so-distant future — particularly as they are increasingly paired with and powered by AI. And while the U.S. historically has demonstrated many underlying strengths in the field, recent research suggests the government may be falling behind China, where biotechnology research efforts and investments have surged since the early 2000s. The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast  on Apple Podcasts, Soundcloud, Spotify and YouTube.

“We have strong scientific foundations and manufacturing excellence. Now we're creating the ecosystem to help biotechs scale and compete globally,” says Federico Vigano, Board Member of Assobiotec.Federico Vigano, Country Manager for Vertex in Italy and Greece, brings extensive pharmaceutical leadership experience from roles at AstraZeneca, Boehringer Ingelheim and GSK. As a board member of Assobiotec, the Italian Association for the Development of Biotechnology representing over 100 companies and research institutes, he coordinates therapeutic areas including access, orphan drugs, advanced therapies, and clinical research.In the latest episode, Federico outlines Italy's ambitious plans to leverage its manufacturing heritage while addressing key barriers to help biotech companies scale from research excellence to commercial success. Read more

In the 20th century, antibiotics transformed medicine. Infections that once killed millions could be cured with a pill or injection. Surgeries became safer, cancer treatments more effective, and advanced medical interventions, such as organ transplants, became possible, all because doctors could rely on these drugs to control infections. Unfortunately, today, that foundation is crumbling. Bacteria are evolving faster than medicine can keep up. Common antibiotics are failing, and infections that were once easily treatable are becoming deadly again. In 2019 alone, antimicrobial resistance was linked to nearly five million deaths worldwide, making it deadlier than HIV or malaria. The economic cost is equally staggering: the World Bank warns of trillions lost in global productivity and millions pushed into poverty if nothing changes. This crisis, caused by antimicrobial resistance, has been described as a “silent pandemic.” Unlike a sudden outbreak, it spreads quietly, making routine medical care slightly more dangerous each year. Yet amid this grim outlook, new research is opening a window of hope. At the forefront of new innovations in this area are Dr. Kai Hilpert of City St George's, University of London, and his colleagues, who are pioneering an approach that combines biology, chemistry, and artificial intelligence to reinvent how we discover infection-fighting medicines. Their work has been recognised with a prestigious award from the UK's Biotechnology and Biological Sciences Research Council, BBSRC.

The Love Bite presents us with a woman's refreshing view of the UFO and alien abduction phenomena. Many people find themselves mysteriously thrown into obsessive relationships, but a few otherwise reliable witnesses claim to have been set up into bonding dramas by alien beings. Eve Lorgen is determined to solve the mystery. By her definition, the Love Bite is a kind of "psychic rape" whereby the victim is abducted, then manipulated into bonding with a targeted love partner chosen by the alien beings. The effects of the Love Bite can range from simple break-ups of platonic relationships, to violent divorces and from "puppy love" to sudden urges to marry a stranger. Through several fascinating case histories, Lorgen demonstrates how the aliens may be orchestrating these dramas for their own ends. It is a if the aliens are harvesting human emotional energy.BioEve Lorgen, MA, is a 30-year dedicated counseling and hypnotherapy professional and anomalous trauma researcher. Her two books: “The Love Bite: Alien Interference in Human Love Relationships, and The Dark Side of Cupid: Love Affairs, The Supernatural and Energy Vampirism reveal compelling case histories of “alien abductees” and experiencers of anomalous relationship set-ups and interdimensional interferences.She began her pioneering work with alien abductees, “milabs” and mind control victims while earning her Masters Degree in Counseling Psychology in 1992. She also holds a BS in Biochemistry and worked in the Biotechnology industry for 7 years. Other studies include Taoist Chi Gong, Meditation and Lucid dreaming practices. Buddhist, Shamanic, Gnostic and Christian Biblical studies. She is now a Christian. She was a close associate of the late Barbara Bartholic and Dr. Karla Turner.The Love Bitehttps://www.amazon.com/dp/B0067QUJ20The Dark Side of Cupidhttps://www.amazon.com/dp/B0FB8RLGCWhttps://evelorgen.com/wp/ https://www.pastliveshypnosis.co.uk/https://www.patreon.com/alienufopodcastMy book 'Verified Near Death Exeriences' https://www.amazon.com/dp/B0DXKRGDFP Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Love Bite presents us with a woman's refreshing view of the UFO and alien abduction phenomena. Many people find themselves mysteriously thrown into obsessive relationships, but a few otherwise reliable witnesses claim to have been set up into bonding dramas by alien beings. Eve Lorgen is determined to solve the mystery. By her definition, the Love Bite is a kind of "psychic rape" whereby the victim is abducted, then manipulated into bonding with a targeted love partner chosen by the alien beings. The effects of the Love Bite can range from simple break-ups of platonic relationships, to violent divorces and from "puppy love" to sudden urges to marry a stranger. Through several fascinating case histories, Lorgen demonstrates how the aliens may be orchestrating these dramas for their own ends. It is a if the aliens are harvesting human emotional energy.BioEve Lorgen, MA, is a 30-year dedicated counseling and hypnotherapy professional and anomalous trauma researcher. Her two books: “The Love Bite: Alien Interference in Human Love Relationships, and The Dark Side of Cupid: Love Affairs, The Supernatural and Energy Vampirism reveal compelling case histories of “alien abductees” and experiencers of anomalous relationship set-ups and interdimensional interferences.She began her pioneering work with alien abductees, “milabs” and mind control victims while earning her Masters Degree in Counseling Psychology in 1992. She also holds a BS in Biochemistry and worked in the Biotechnology industry for 7 years. Other studies include Taoist Chi Gong, Meditation and Lucid dreaming practices. Buddhist, Shamanic, Gnostic and Christian Biblical studies. She is now a Christian. She was a close associate of the late Barbara Bartholic and Dr. Karla Turner.The Love Bitehttps://www.amazon.com/dp/B0067QUJ20The Dark Side of Cupidhttps://www.amazon.com/dp/B0FB8RLGCWhttps://evelorgen.com/wp/ https://www.pastliveshypnosis.co.uk/https://www.patreon.com/alienufopodcastMy book 'Verified Near Death Exeriences' https://www.amazon.com/dp/B0DXKRGDFP Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Quinzaine de L' Agriculture TinctorialeÊtes-vous prêt à plonger dans l'univers fascinant de la couleur végétale et des plantes tinctoriales ? Dans cet épisode captivant d'ArtEcoVert La voix de la couleur végétale et des plantes tinctoriales, nous avons le plaisir d'accueillir Pauline Leroux, une véritable passionnée et experte en matière de teinture naturelle. Elle nous dévoile le programme riche et varié de la quatrième édition de la quinzaine de l'agriculture tinctoriale d'ArtEcoVert, qui se déroulera du 17 au 28 novembre. Cette quinzaine de l'agriculture tinctoriale promet d'être une célébration inoubliable de la teinture végétale, avec une multitude d'événements organisés chaque jour, à l'exception du mercredi. Vous aurez l'occasion d'entendre des intervenants de renom, tels que Marie Marquet, qui partagera son expertise sur la culture des plantes tinctoriales. À travers des témoignages émouvants d'agriculteurs des Hauts-de-France et de Bretagne, nous explorerons les défis et les réussites de ceux qui se consacrent à cette pratique ancestrale. Les thèmes abordés dans cet épisode incluent les fibres naturelles, les techniques de teinture végétale, et des méthodes spécifiques comme celle du sukumo, essentielle pour la conservation des feuilles de persicaire. Ces savoir-faire traditionnels sont plus que jamais d'actualité dans notre quête de durabilité et de respect de l'environnement. Pauline nous invite à nous engager activement dans cet événement, en partageant les modalités d'inscription et les opportunités de participation pour les membres de la communauté d'ArtEcoVert. Ne manquez pas cette chance unique de découvrir les merveilles de la couleur végétale et d'apprendre des experts du domaine. Pour ceux qui souhaitent approfondir leur connaissance des plantes tinctoriales et de la teinture naturelle, cet épisode est une véritable mine d'informations. Que vous soyez novice ou expert, vous trouverez des conseils pratiques et des idées inspirantes pour intégrer ces techniques dans votre propre parcours créatif. Ensemble, faisons de la teinture végétale un acte engagé et conscient. Écoutez cet épisode pour découvrir comment vous pouvez vous aussi participer à cette belle aventure teintoriale. Belle écoute ! ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

V podcastoch Poradcu podnikateľa vám chceme prinášať aj inšpiratívne príbehy slovenských firiem, ktoré robia našu spoločnosť lepšou a (v prípade našich dnešných hostí) aj zdravšou. Dnes sa porozprávame o tom, ako sa dvaja doktori farmácie rozhodli spojiť prírodu s vedou a na slovenský trh priniesli výživové doplnky a nutraceutiká – teda prírodné látky alebo produkty z prírodných zdrojov, ktoré majú nielen výživové, ale aj liečivé účinky.Aká je z ich skúsenosti realita podnikania na Slovensku? Aké sú špecifiká slovenského trhu s výživovými doplnkami?Našimi dnešnými hosťami sú farmaceuti a spoluzakladatelia AVROPA Biotechnology, bratia Miroslav a Peter Švecovci zo Zvolena.Rozprávali sme sa:Aká bola ich cesta k lekárnictvu a v akom prostredí vyrastali?Čo ich presvedčilo, aby zostali na Slovensku a neodišli po štúdiách do zahraničia?Prečo sa rozhodli venovať výživovým doplnkom a ako vznikla značka AVROPA?Ako je možné spájať vedecké poznatky s prírodnými surovinami?Ako vzniká výživový doplnok – od nápadu až po konečný produkt? Koľko celý proces zvyčajne trvá?Prečo je kvalita a bezpečnosť produktov pre nich kľúčová? Pre koho sú ich produkty určené a aké je ich poslanie?Aké je na Slovensku podnikanie vo sfére výživových doplnkov?Aké sú ich plány do budúcnosti?Čo našich hostí na ich práci najviac napĺňa a prečo ich to baví?A na záver nebude chýbať ani zopár tipov a odporúčaní pre podnikateľov.Sme Poradca podnikateľa – vzdelávame, inšpirujeme, povzbudzujeme.www.pp.sk

This episode is sponsored by AGNTCY. Unlock agents at scale with an open Internet of Agents. Visit https://agntcy.org/ and add your support. Can AI and RNA testing make illness optional? In this episode, Eye on AI host Craig S. Smith sits down with Naveen Jain, founder and CEO of Viome, to explore how RNA sequencing and artificial intelligence are transforming our understanding of chronic disease. Jain shares how a personal tragedy led him to launch Viome, a company on a mission to digitize the human body, predict illness before symptoms appear, and revolutionize healthcare. Together they discuss how Viome uses metatranscriptomics to analyze microbiome and human gene expression, what makes RNA a better indicator of health than DNA, and how large molecular AI models are paving the way for early detection of cancer, diabetes, Alzheimer's, and more. Jain also reveals his bold entrepreneurial framework—“Why this, why now, why me?”—and his belief that asking better questions is the real key to innovation. If you're interested in the intersection of AI, biotechnology, and human longevity, this is an episode you won't want to miss. Stay Updated: Craig Smith on X:https://x.com/craigss Eye on A.I. on X: https://x.com/EyeOn_AI

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lars, covering: The difficult decision to leave Novo Nordisk and make the jump from one great company to another in Genentech/Roche. How leaving a Biogen site led him to step away from big pharma after 25 years and transition to the CDMO side. How Fujifilm's culture of innovation, technology, quality, and people runs through the Biotechnologies division — and why empowerment and culture should never be compromised. Why the duplication of its CDMO sites globally, all running on the same kojoX platform, is truly differentiating. Why he believes the need to standardise, scale, and globalise drug production in a consistent, efficient, and traceable way is key to the future of the supply chain. Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by Lead Candidate.    Lars Petersen, CEO of FUJIFILM Biotechnologies, is recognized as a visionary leader in the life science sector, commanding a global contract development and manufacturing organization (CDMO) with nearly 5,000 employees spread across Denmark, UK, USA, and Japan.    Distinguished for his strategic vision and a "people first" philosophy, Lars has profoundly impacted the company and the industry. His leadership journey saw him rise from Chief Operational Officer & Senior Vice President at the Danish site, where he established an empowering culture, to CEO, promoting transparency across all operations. Since his global leadership appointment in June 2023, Lars has been instrumental in cultural transformation, integrating a "people first" approach across FUJIFILM Biotechnologies' global facilities regardless of geographical differences.   Prior to his appointment as CEO, Lars was responsible for the Global Large Scale Commercial operation including full profit and loss accountability as well as the responsibility for over $6.2 Billion global expansions both in Hillerød, Denmark, and Holly Springs, North Carolina, USA.   Previously, Lars has held leadership positions with Biogen, Genentech/Roche, Novo Nordisk, Novozymes and NNE, and he has successfully executed projects in Europe, China and the US.   Lars holds a master's degree from the Technical University of Denmark.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! 

Dr. Nicole Paulk is the CEO, Founder, and President of Siren Biotechnology and has dedicated her career to advancing the field of gene therapy. With nearly two decades of expertise, Nicole has been at the forefront of developing cutting-edge advances to propel the field of gene therapy forward for a wide range of diseases. Nicole has held various leadership positions in academia and industry and most notably was an Assistant Professor of AAV Gene Therapy in the UCSF Department of Biochemistry & Biophysics before leaving to found Siren. Nicole has a B.S. in Medical Microbiology, a Ph.D. in Viral Gene Therapy and Regenerative Medicine from OHSU and completed her Postdoctoral Fellowship and Instructorship in Human Gene Therapy at Stanford University prior to starting her lab at UCSF. Nicole is a pioneer in the development of next-generation AAV platforms for gene repair, gene transfer and gene editing, directed evolution for novel engineered capsid evolution, and comparative multi-omic approaches to interrogate translational AAV biology.

Serial entrepreneur Michael Heltzen, CEO of Exozymes, reveals how his NASDAQ-listed company is "liberating enzymes from cells" to create a new generation of chemical manufacturing. Instead of using living cells as factories, Exozymes isolates enzymatic pathways to work as pure chemistry—achieving engineering-level control previously deemed impossible in conventional synthetic biology. Michael discusses Exozymes' AI-powered enzyme evolution, six-week development timelines, bold IPO strategy during biotech's funding winter, and applications in pharmaceuticals like NCT for liver disease. This is synthetic biology's next chapter: sustainable, scalable enzyme-based manufacturing that could replace both petrochemicals and natural harvesting. Make sure to check out eXoZymes' website: https://exozymes.com/ Follow our Instagram @insidebiotech for updates about episodes and upcoming guests! To learn more about BCLA's events and consulting visit our website.Follow BCLA on LinkedIn

How to know if your dog is happy? Did you know that dogs basically have all the same brain structures for producing emotions that we have? Japanese scientists from the Department of Animal Science and Biotechnology at Azabu University along with specialists from other Japanese universities conducted a study that showed how dogs develop strong emotional connections with humans by staring into their eyes! Dogs are pack animals by nature, which makes them seek closeness with their pack — and you are naturally one of them! Specialists believe that dogs lean and touch their owners for physical and emotional support, seeing them as someone who can protect and comfort them. Learn more about your ad choices. Visit megaphone.fm/adchoices

Avez-vous déjà pensé à la richesse cachée derrière la couleur rouge qui embellit tant de produits que nous utilisons au quotidien ? Dans cet épisode captivant d'ArtEcoVert, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome passionnée par la couleur végétale et les plantes tinctoriales, qui nous entraîne dans un voyage fascinant à travers l'univers du carmin. Ce pigment emblématique, dérivé de la cochenille, ne se contente pas d'apporter une teinte vibrante, il est également chargé d'histoire et de significations économiques. Pauline nous révèle comment cet insecte, vivant sur le figuier de Barbarie, secrète l'acide carminique, transformé en un rouge profond et stable qui a traversé les âges. En retraçant l'histoire du carmin, elle nous plonge dans la période de la conquête espagnole au Mexique, où les Aztèques l'utilisaient déjà pour ses propriétés colorantes. Mais saviez-vous que le carmin a également joué un rôle crucial dans le commerce colonial, devenant un produit de valeur inestimable ? Au fil de la conversation, Pauline aborde les défis contemporains auxquels le carmin fait face, notamment l'impact des colorants synthétiques qui ont bouleversé le marché à la fin du XIXe siècle. Comment ce pigment traditionnel s'inscrit-il dans notre monde moderne, notamment dans l'alimentation, la cosmétique, et même l'art ? Les questions éthiques se posent également : le carmin est-il compatible avec les valeurs véganes ? Quels sont les risques allergiques associés à son utilisation ? Avec un ton bienveillant et engagé, cet épisode d'ArtEcoVert met en lumière non seulement la richesse historique du carmin, mais aussi son rôle actuel dans notre société. Que vous soyez passionné par la couleur végétale, curieux des plantes tinctoriales, ou simplement désireux d'en apprendre davantage sur l'impact de nos choix de consommation, cet épisode est fait pour vous. N'oubliez pas de consulter les liens utiles que nous avons préparés pour approfondir votre connaissance du carmin et de son histoire fascinante. Rejoignez-nous pour une belle écoute avec Pauline, et laissez-vous inspirer par la voix de la couleur végétale et des plantes tinctoriales ! ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

We have reached the end of another week here at Charlottesville Community Engagement and all that is left to do is put together an audio version using the stories already told. Listening might become habit-forming if you have an interest in discussions about the future, and if you want to spot the mistakes. Is this the one where I leave in the curse words? Tune in!If not, this edition also serves as a way to remind you of some of the stories this week.In this edition:* Albemarle Planning Commission takes a look at the county's draft Comprehensive Plan (read the story)* Albemarle Supervisors discuss 2025 build-out analysis (read the story)* Albemarle PC recommends approval of new rule to allow taller buildings in industrial districts (read the story)* Manning Institute of Biotechnology director outlines hope for creating new medicine (read the story on C-Ville Weekly)* Charlottesville poised to appropriate fourth state grant for flood preparation (learn more)Sponsored message: Westwind FlowersAt Westwind Flowers the Dahlia fields are in full bloom with a stunning array of colors and varieties that only this season can offer.You're invited to experience it for yourself on September 27th and October 4th during their Dahlia U-Pick events at their farm, located on the historic grounds of James Madison's Montpelier. It's a chance to stroll through the fields, cut your own flowers, and soak in the beauty of the season—a flower lover's dream come true!Can't make it to their Dahlia U-Pick event? They can bring the season to you! Order your locally grown, freshly harvested bouquets today, available for pickup at their Gordonsville floral studio or delivered straight to your home, your office, or someone special.Westwind Flowers offers sustainably grown, thoughtfully curated cut flowers, perfectly suited to the season and the special moments in your life. They believe the blooms in your vase should be just as fresh, and just as local, as the food on your table.To register for a Dahlia U-Pick, order seasonal flowers, or learn more, visit westwindflowers.com. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit communityengagement.substack.com/subscribe

Kerry, a global leader in taste and nutrition, has inaugurated the Kerry Biotechnology Centre in Leipzig, Germany, which will focus on the development of innovative biotech solutions across food, beverage, and pharma applications. New capabilities in biotechnology are opening the field to discoveries and opportunities for innovative market solutions that can increase efficiencies across a range of food production processes, overcome ingredient scarcity, and create products tailored to precise needs - improving human health and product functionality. Kerry has significantly developed its biotechnology capabilities in recent years, having built a dedicated technology and manufacturing footprint through a combination of strategic acquisitions and organic investment. The Biotechnology Centre in Leipzig will further enhance Kerry's global infrastructure in this space. Leipzig has been chosen as the location for the new facility, given the exceptional biotechnology skills base and research cluster that has developed in the city. c-LEcta, which was acquired by Kerry in 2022 for its specialist capabilities in enzymes and biotechnology, was itself established in 2004 as a spin-out from the University of Leipzig. Kerry's biotechnology research and production infrastructure spans three continents and is led and co-ordinated from Kerry's Global Innovation Centre in Ireland. Aligned with the Group's sustainable nutrition strategy, the new Biotechnology Centre in Leipzig will be directed by Dr. Marc Struhalla, the founder of c-LEcta, and will draw on the work of over 100 scientists and technical experts, including 34 PhDs based in the centre. The primary activities that will be undertaken at the new facility include enzyme and strain identification and engineering, fermentation and bioprocess development and scale-up, and production. Novel enzymes are selected from nature, and can then be tailored to perform specific functions with applications in a broad spectrum of use cases. Some of the innovative products utilising biotech capabilities which have already been commercialised by Kerry include; ACRYLERASE - a new-to-world enzyme solution capable of removing acrylamide in instant coffee; DENARASE - a best-in-class enzyme solution designed to remove residual DNA and utilised in the manufacturing of vaccines and gene and cell therapies; BIOBAKE - enzymes which dramatically increases shelf-life, and processability of baked products. Marking the opening in Leipzig, Kerry CEO, Edmond Scanlon said: "Biotechnology solutions present a new horizon of innovation and opportunity for global food, beverage and pharmaceutical markets. Kerry's existing portfolio of biotech capabilities, which has been built up over the past 20 years, together with this new Biotechnology Centre, enables us to play a leading role in bringing the next generation of discoveries in this space to market, supporting our customers, as they meet consumer needs for sustainable nutrition". See more stories here.

Allonnia CEO Nicole Richards speaks with CleanTechnica COO Scott Cooney about leveraging the power of biotechnology to help clean up mining, get PFAS "forever chemicals" out of our environment, and move us toward a waste-free world.

Allonnia CEO Nicole Richards speaks with CleanTechnica COO Scott Cooney about leveraging the power of biotechnology to help clean up mining, get PFAS "forever chemicals" out of our environment, and move us toward a waste-free world.

Savez-vous que la chlorophylle, ce pigment vert qui donne vie à nos plantes, joue un rôle fondamental non seulement dans la photosynthèse, mais aussi dans de nombreuses applications humaines ? Dans cet épisode captivant du podcast ArtEcoVert La voix de la couleur végétale et des plantes tinctoriales, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome passionnée par la couleur végétale et les plantes tinctoriales. Avec son expertise, elle nous plonge dans l'univers fascinant de la chlorophylle, ce pigment essentiel à la vie sur Terre. Au cours de cette discussion enrichissante, Pauline nous explique comment la chlorophylle permet aux plantes de convertir la lumière en énergie chimique, un processus vital qui soutient toute la chaîne alimentaire. Elle aborde également le paradoxe de la capture et de la stabilisation de ce pigment dans les pratiques humaines, soulevant des questions cruciales sur notre interaction avec la nature. Vous découvrirez les différents types de chlorophylle et leurs propriétés uniques, ainsi que leurs applications innovantes dans des domaines variés tels que le textile, l'alimentation et la cosmétique. Mais ce n'est pas tout ! Pauline partage également des défis passionnants liés à la stabilité de la chlorophylle, notamment sa tendance à se dégrader rapidement. Elle propose des solutions prometteuses, telles que l'encapsulation et l'utilisation de mélanges pigmentaires, pour garantir que ce précieux pigment puisse être utilisé de manière durable et efficace. En fin de compte, cet épisode met en lumière l'importance cruciale de la recherche sur la chlorophylle et son potentiel dans des applications futures. Avec une approche bienveillante et pédagogique, Pauline nous invite à explorer davantage ce sujet fascinant et à envisager comment nous pouvons intégrer ces connaissances dans notre quotidien. Ne manquez pas cette occasion d'en apprendre davantage sur la chlorophylle et son impact sur notre vie ! Écoutez cet épisode inspirant de ArtEcoVert La voix de la couleur végétale et des plantes tinctoriales et laissez-vous emporter par la magie de la couleur végétale. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

Recently, the new embryo-selection start-up Herasight has been in the news, finally coming out of stealth. Part of the buzz is because of the public involvement of well-known geneticists and academics like Alex Young and Joe Pickrell in Herasight's algorithm development. Additionally, Noor Siddiqi, the CEO of Orchid, a competitor to Herasight (and onetime advertiser on this podcast), was a guest on Ross Douthat's show Interesting Times, triggering another round of conversations around embryo-selection, including in The Wall Street Journal and Breaking Points. To hash out some opposing viewpoints, Unsupervised Learning decided to bring on two guests that stake out very different positions, Dr. James Lee, a psychometrician and behavior geneticist at the University of Minnesota, and Dr. Jonathan Anomaly, a philosopher and Herasight's sales lead. Lee has been on the record with his skepticism of reproductive technology, writing an op-ed in The Wall Street Journal four years ago warning against the consequences of polygenic embryo selection. Meanwhile, Anomaly's last book was Creating Future People: The Science and Ethics of Genetic Enhancement, where he advances the idea that such technologies will unlock human potential.

Christopher Macklin is an spiritual and metaphysical lecturer, author, remote viewer who shares his insights in the fields of spirituality, health and wellness and the paranormal. His topics includes SADS, 5G's and the affects on the public, UFO's, The Galactic Federation, raising the immune system, Divine Sovereignty, Cause and Effect of Illness, lectures on theaphysical, spiritual and emotional guide to health & wellness. Born as a highly aware psychic child in Chester, England, Christopher Macklin was able to perceive energy fields, spirit activity and multi-dimensional phenomena from a very young age. His life as a successful aviation industry engineer came to an abrupt end when a failed real estate venture caused a series of financial difficulties that resulted in Christopher living out of the back of his car, homeless on the streets of Manchester, England. In a very short period of time, Christopher found the world as he knew it turned upside down. Newly divorced, his money all gone and unable to get a job, he began to understand that the Divine had other plans for him. In a pivotal moment sitting in a square in Manchester with nothing to call his own and nowhere to go, he promised himself and God that he would use his healing abilities to serve and he surrendered the rest to God.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-x-zone-radio-tv-show--1078348/support.Please note that all XZBN radio and/or television shows are Copyright © REL-MAR McConnell Meda Company, Niagara, Ontario, Canada – www.rel-mar.com. For more Episodes of this show and all shows produced, broadcasted and syndicated from REL-MAR McConell Media Company and The 'X' Zone Broadcast Network and the 'X' Zone TV Channell, visit www.xzbn.net. For programming, distribution, and syndication inquiries, email programming@xzbn.net.We are proud to announce the we have launched TWATNews.com, launched in August 2025.TWATNews.com is an independent online news platform dedicated to uncovering the truth about Donald Trump and his ongoing influence in politics, business, and society. Unlike mainstream outlets that often sanitize, soften, or ignore stories that challenge Trump and his allies, TWATNews digs deeper to deliver hard-hitting articles, investigative features, and sharp commentary that mainstream media won't touch.These are stories and articles that you will not read anywhere else.Our mission is simple: to expose corruption, lies, and authoritarian tendencies while giving voice to the perspectives and evidence that are often marginalized or buried by corporate-controlled media. 

AI accelerates drug discovery while steroids turn teens into aggressive strangers. Dr. Michael Israetel explores our pharmaceutical crossroads here!Full show notes and resources can be found here: jordanharbinger.com/1209What We Discuss with Michael Israetel:GLP-1 drugs like Tirzepatide offer massive health benefits beyond weight loss — reducing inflammation, improving brain health, and decreasing addiction behaviors, even for people already in good shape.Steroids don't just amplify personality — they specifically amplify masculine traits like aggression and reduce empathy. Starting young can permanently rewire your brain's emotional and social processing.AI is about to revolutionize medicine by testing millions of drug candidates virtually, creating treatments 10x more effective with 10x fewer side effects. We're entering the pharmaceutical iPhone moment.The "only take drugs when sick" mindset worked in the 20th century, but is becoming dangerously outdated — like refusing elevators because you prefer human operators.When your diet plateaus, take a week-long break eating at maintenance. Your stress hormones will drop, body water will flush out, and you'll often look leaner than before.And much more...And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:Saily: 15% off: saily.com/jordanharbinger, code JORDANHARBINGERDripDrop: 20% off: DripDrop.com, code JORDANLinkedIn Jobs: Post your job for free: linkedin.com/jordanQuince: Free shipping & 365-day returns: quince.com/jordanBetterHelp: 10% off first month: betterhelp.com/jordanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week's episode features Nicole Richards, CEO of Allonnia, a biotechnology company developing innovative solutions for mining waste. Richards discusses how recent advances in biotech in the last five years are enabling cost-effective, efficient, and environmentally sustainable approaches to one of the industry's toughest challenges. All this and more with host Adrian Pocobelli. “Rattlesnake Railroad”, “Big Western Sky”, “Western Adventure” and “Battle on the Western Frontier” by Brett Van Donsel (⁠www.incompetech.com⁠). Licensed under Creative Commons: By Attribution 4.0 License ⁠creativecommons.org/licenses/by/4.0⁠ Apple Podcasts:⁠ https://podcasts.apple.com/ca/podcast/the-northern-miner-podcast/id1099281201⁠ Spotify:⁠ https://open.spotify.com/show/78lyjMTRlRwZxQwz2fwQ4K⁠ YouTube:⁠ https://www.youtube.com/@NorthernMiner⁠ Soundcloud:⁠ https://soundcloud.com/northern-miner

Suivez la série COULEURS DU VIVANT : ICI Savez-vous que les champignons pourraient bien être la clé d'une révolution dans le monde de la couleur végétale et des matériaux durables ? Dans cet épisode captivant du podcast ArtEcoVert, Pauline Leroux accueille Elodie Choque, maître de conférence àl'Université de Picardie Jules Verne, pour plonger au cœur de l'univers fascinant des champignons, de la biotechnologie et de la couleur végétale. Elodie, passionnée par les champignons, notamment ceux qui produisent des couleurs, nous fait découvrir son parcours académique et son enthousiasme contagieux pour ces organismes extraordinaires.Ensemble, ils explorent comment ces êtres vivants, qu'ils soient unicellulaires comme les levures ou filamenteux, jouent un rôle essentiel dans des domaines variés tels que l'alimentation, la construction, et même la cosmétique. L'épisode met en lumière l'importance des champignons dans la création de bioplastiques, leur potentiel pour dépolluer les sols, ainsi que leur utilisation dans des applications innovantes comme le smart packaging. Elodie souligne que les champignons ne sont pas seulement une source de couleur, mais également des alliés précieux dans la lutte contre les plastiques non biodégradables.Ce dialogue riche et engagé met en avant la nécessité d'intégrer les connaissances sur les champignons dans les pratiques durables, tout en insistant sur l'importance de la recherche collaborative dans ce domaine. Les colorants végétaux, issus de la teinture végétale et des plantes tinctoriales comme l'indigo et la garance, trouvent une nouvelle dimension grâce à la biotechnologie fongique. Les pigments végétaux et les tanins, extraits de fibres naturelles, offrent une palette de nuances qui pourrait transformer notre approche de la couleur et de la teinture.En conclusion, cet épisode se termine sur une note d'optimisme quant à l'avenir de la biotechnologie fongique. Elodie Choque nous invite à envisager un monde où les matériaux et les couleurs sont non seulement esthétiques mais aussi durables, en harmonie avec notre environnement. Ne manquez pas cette occasion d'en apprendre davantage sur l'impact des champignons dans l'agriculture tinctoriale et les jardins de demain. Pour écouter cet épisode inspirant, rendez-vous sur notre site ArtEcoVert et plongez dans l'univers des colorants biosourcés. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

In this episode, Lisa, Dr. Corbin, and Catie discuss:Mentorship as a driver of growth and opportunityThe mutual responsibilities within mentor–mentee relationshipsEarly guidance shaping confidence and career directionPaying forward lessons learned through mentoring othersKey Takeaways: Mentorship offers students personalized support, creating opportunities that money alone cannot provide.Advocating for oneself and asking for help early—whether in high school classrooms or college —can build the confidence needed to persist in challenging subjects.Successful mentorship is not about rigid schedules but about mentees taking initiative, showing preparedness, and seeking guidance when it's most needed.Recognition can follow when students demonstrate leadership by mentoring younger peers, developing rigorous learning systems, and fostering strong academic communities.“If you're a scientist in the STEM field, and you've never mentored anybody… I promise that any effort and time you spend mentoring will be rewarding, both for your mentee and for you.” – Dr. Karen Corbin“Mentorship has always been a really important aspect of my life, and I do think something I'm very good at is advocating for myself and asking for help.” – Catie KeanAbout Dr. Karen Corbin and Catie Kean: Dr. Karen Corbin is an Associate Investigator at the AdventHealth Translational Research Institute. Since August 2024, she has mentored Catie Kean through the Astronaut Scholarship Foundation, supporting her academic journey and professional development.Catie Kean is a 2024 Astronaut Scholar with the Astronaut Scholarship Foundation and a recent graduate with a Bachelor of Science in Biology and Biotechnology. She earned an Honorable Mention for the NSF Graduate Research Fellowship Program and will begin her PhD in Molecular, Cellular, and Developmental Biology at the University of Colorado Boulder in August 2025.Episode References:Explore more resources to support students' growth and clarity by visiting the free tools Join ASF's Mentorship Program to support the newly announced 2025 Astronaut Scholars and help shape the future of scienceGet Lisa's Free on-demand video: How-to guide for your teen to choose the right major, college, & career...(without painting themselves into a corner, missing crucial deadlines, or risking choices you both regret). Connect with the Astronaut Scholarship Foundation:Instagram: https://www.instagram.com/astroscholarfdn/?hl=en Facebook: https://www.facebook.com/AstroScholarFdn/LinkedIn: https://www.linkedin.com/company/astronaut-scholarship-foundation/Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoFacebook: https://www.facebooke.com/flourishcoachingco/Instagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

Savez-vous que les tanins, ces composés végétaux fascinants, sont bien plus qu'une simple curiosité de la nature ? Dans cet épisode d'ArtEcoVert, Pauline Leroux, ingénieure agronome passionnée de couleur végétale, reçoit Marc-André Sélosse, professeur au Muséum National d'Histoire Naturelle, pour un voyage captivant au cœur des tanins et de leur rôle essentiel dans la teinture végétale.Ensemble, ils plongent dans l'univers des plantes tinctoriales, explorant comment ces substances naturelles influencent non seulement la couleur des textiles mais aussi notre santé et notre environnement. Marc-André partage sa vision sur la vulgarisation scientifique, affirmant que la complexité des tanins peut être perçue comme une beauté. Il définit les tanins, explique leur rôle dans la teinture et souligne leur importance écologique, tout en évoquant des applications modernes dans des domaines variés tels que l'alimentation, la santé, et même la cosmétique.Découvrez comment les tanins interagissent avec les protéines, influençant des aspects comme l'astringence et la couleur, et comment ils peuvent être utilisés pour créer des colorants biosourcés d'une richesse inégalée. Les discussions techniques de cet épisode mettent en lumière l'importance de la biodiversité et de l'agriculture durable, tout en offrant un aperçu des perspectives d'avenir pour l'utilisation des tanins dans le bâtiment et d'autres secteurs innovants.Marc-André nous invite à réfléchir sur les nuances que peuvent offrir les pigments végétaux et les fibres naturelles, tout en soulignant l'importance de préserver notre patrimoine végétal. Que vous soyez un passionné de teinture végétale, un amateur de couleur végétale, ou simplement curieux d'en apprendre davantage sur les plantes et leur impact sur notre quotidien, cet épisode est fait pour vous.Ne manquez pas cette occasion d'enrichir vos connaissances et d'adopter une approche plus respectueuse de l'environnement grâce aux tanins et aux plantes tinctoriales. Écoutez dès maintenant cet épisode d'ArtEcoVert pour explorer un monde où la couleur et la nature se rencontrent de manière harmonieuse et durable. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

On the latest episode of the GZERO World podcast, Ian Bremmer talks with world-renowned cancer researcher and Pulitzer Prize-winning author Siddhartha Mukherjee about the future of medicine—and why artificial intelligence might finally tip the scales in the decades-long war on cancer.Cancer remains the second leading cause of death in the US, killing nearly 1,700 people every day. But Mukherjee says AI is already reshaping the field, from radiology and diagnostics to identifying new carcinogens and designing entirely new cancer drugs. “Every time we do this in collaboration with a machine,” he explains, “the machine learns it, and it learns it forever.”In a wide-ranging conversation, Mukherjee breaks down three major areas where AI is advancing medicine: patient care, data mining, and generative drug development. He also weighs in on early cancer detection, how inflammation may hold the key to understanding new carcinogens, and why this moment may be the most hopeful in half a century of cancer research.Host: Ian BremmerGuest: Siddhartha Mukherjee Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.

On the latest episode of the GZERO World podcast, Ian Bremmer talks with world-renowned cancer researcher and Pulitzer Prize-winning author Siddhartha Mukherjee about the future of medicine—and why artificial intelligence might finally tip the scales in the decades-long war on cancer.Cancer remains the second leading cause of death in the US, killing nearly 1,700 people every day. But Mukherjee says AI is already reshaping the field, from radiology and diagnostics to identifying new carcinogens and designing entirely new cancer drugs. “Every time we do this in collaboration with a machine,” he explains, “the machine learns it, and it learns it forever.”In a wide-ranging conversation, Mukherjee breaks down three major areas where AI is advancing medicine: patient care, data mining, and generative drug development. He also weighs in on early cancer detection, how inflammation may hold the key to understanding new carcinogens, and why this moment may be the most hopeful in half a century of cancer research.Host: Ian BremmerGuest: Siddhartha Mukherjee Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. CDC Director Monarez was fired after less than a month due to internal unrest over new COVID-19 vaccine policies. Novo Nordisk is investing over $500 million in RNA obesity treatments. The FDA has approved updated COVID-19 shots from Pfizer, Moderna, and Novavax with restrictions, causing concern among some groups. Prothena's Alzheimer's drug, PRX012, has shown high rates of brain swelling in Phase I testing. Novo Nordisk is collaborating with other companies on cardiometabolic treatments. The pharma industry is facing challenges and changes, with layoffs and restructurings occurring at various companies. Massachusetts has seen a decline in R&D and biomanufacturing jobs in 2024. Various webinars and events are being held to discuss topics such as pharma manufacturing and data accessibility. Job opportunities in the pharmaceutical industry include positions in business analysis, quality engineering, and project engineering.

Biotechnology startup OGI Biotec adopted manufacturing software early on to get its fledgling production off the ground, a move that quickly proved beneficial. You can learn more in this episode or read about it on our blog For more information about MRPeasy software, visit our website: mrpeasy.com

Biotechnology company Genentech broke ground on its first east coast facility on Monday. It plans to hire 420 people in Holly Springs as it works on developing obesity drugs. WRAL's Shaun Gallagher explains what the company's plans are over the next five years.

Dr. Frank Bedu-Addo, President and CEO of PDS Biotechnology, focuses on the challenge of cancer recurrence and the development of a targeted immunotherapy approach using nanoparticle technology. Their lead immunotherapy candidate is designed to train the immune system to detect and attack microscopic or undetectable cancer cells, prolonging survival by preventing recurrence. Early clinical results in cervical, head and neck, and other HPV 16-positive cancers have been promising, showing sustained immune response leading to long-lasting T cell memory.  Frank explains, "Recurrence of cancer after treatment is actually one of the bigger hurdles we face in successfully treating cancer. So, PDS Biotechnology, as you know, we have a sharp focus on advancing our targeted immunotherapy platforms to address significant unmet needs in treating cancer. And this is actually one of those key unmet needs in cancer today. The prevailing hypothesis on knowledge is that cancer treatment, whether it's done using radiation therapy or anti-cancer drugs such as chemotherapy, both methods actually work by destroying cancer cells or halting the growth."   "And so what may happen with time is that these remaining cancer cells may then grow until they can be detected or begin to cause symptoms. Now, even if the cancer has been removed by surgery, there is still a risk that some tiny microscopic cancer cells could still remain in the body. We would therefore expect the ideal immunotherapy to be able to detect these tiny microscopic cancer cells, even if they have spread to other parts of the body."  #PDSBiotech #Cancer #CancerVaccines #ImmunoOncology #CancerRecurrence PDSbiotech.com Download the transcript here  

Dr. Frank Bedu-Addo, President and CEO of PDS Biotechnology, focuses on the challenge of cancer recurrence and the development of a targeted immunotherapy approach using nanoparticle technology. Their lead immunotherapy candidate is designed to train the immune system to detect and attack microscopic or undetectable cancer cells, prolonging survival by preventing recurrence. Early clinical results in cervical, head and neck, and other HPV 16-positive cancers have been promising, showing sustained immune response leading to long-lasting T cell memory.  Frank explains, "Recurrence of cancer after treatment is actually one of the bigger hurdles we face in successfully treating cancer. So, PDS Biotechnology, as you know, we have a sharp focus on advancing our targeted immunotherapy platforms to address significant unmet needs in treating cancer. And this is actually one of those key unmet needs in cancer today. The prevailing hypothesis on knowledge is that cancer treatment, whether it's done using radiation therapy or anti-cancer drugs such as chemotherapy, both methods actually work by destroying cancer cells or halting the growth."   "And so what may happen with time is that these remaining cancer cells may then grow until they can be detected or begin to cause symptoms. Now, even if the cancer has been removed by surgery, there is still a risk that some tiny microscopic cancer cells could still remain in the body. We would therefore expect the ideal immunotherapy to be able to detect these tiny microscopic cancer cells, even if they have spread to other parts of the body."  #PDSBiotech #Cancer #CancerVaccines #ImmunoOncology #CancerRecurrence PDSbiotech.com Listen to the podcast here  

We've long marveled at how efficiently plants convert sunlight into energy—but no one guessed they were using quantum mechanics to do it.In this episode, we speak with Greg Engel, a pioneering University of Chicago biophysicist who helped launch the field of quantum biology. Engel explains how plants and bacteria evolved to exploit quantum effects for photosynthesis—and how understanding these systems could spark a revolution in quantum sensing, medicine, and neuroscience.Engel's team has already built quantum sensors inspired by nature's designs, with the potential to transform how we detect disease, develop drugs, and even read neural signals. The ultimate goal? A new era of quantum medicine, powered by the weird and wonderful physics found in leaves.

The Katrina 20 Local Planning Committee is commemorating Hurricane Katrina with performances, art and more, throughout the city, stretching to Mississippi and Alabama.The Coastal Desk's Eva Tesfaye spoke with Asali deVan Ecclesiastes, executive director of the Ashé Cultural Arts Center, to learn more about the events and how you can get involved. For months, the Trump administration has been cutting funding for university-based scientific research across the nation. But the Louisiana Biomedical Research Network recently logged a ‘win'with the renewal of one of its grants from the National Institute of Health–$20 million spread out over five years.Dr. Konstantin "Gus" Kousoulas, a professor and department head in the LSU School Veterinary Medicine's Department of Pathobiological Sciences and director of their Division of Biotechnology and Molecular Medicine, joined us to discuss the grant and how it will be used.—Today's episode of Louisiana Considered was hosted by Adam Vos. Our managing producer is Alana Schreiber. We get production support from Garrett Pittman and our assistant producer Aubry Procell.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App and wherever you get your podcasts. Louisiana Considered wants to hear from you!Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

Welcome to the Securing Our Future podcast, where we explore the synergy between commercial innovation and national security. In this episode, we sit down with Dawn Meyerriecks, an expert with over 40 years of experience in government and industry, to discuss the profound technological advancements from Desert Storm to AI and quantum computing. Dawn shares insights into the adoption of new technologies, the role of government and private sectors, and the importance of finding the right champions for innovation. We also delve into the emerging field of biotechnology and its transformative implications for national security. Join us for an engaging conversation that bridges the gap between innovation and security.00:00 Introduction to Securing Our Future Podcast00:41 Guest Introduction: Dawn's Storied Career01:05 Technological Evolution and National Security02:49 Challenges of Rapid Technological Change04:27 Leadership and Innovation in Government06:37 Startups and Government Collaboration12:34 Biotechnology and National Security19:00 Future Directions and Personal Reflections25:20 Closing Remarks and Acknowledgements

ORIGINAL AIR DATE: AUG 2, 2015An amazing conversation from a decade ago with the amazing Dr. Thomas Horn, on the subject of Transhumanism.Here is the documentary Tom refers to: https://www.youtube.com/watch?v=8QG1EgkpJX4Sheila's content is viewer supported.SHEILA WEBSITE: https://sheilazilinsky.comHOW TO GIVE: https://sheilazilinsky.com/givingVenmo https://venmo.com/u/SheilaZilinskyCash app https://cash.app/$SheilaZilinskyZelle sheila@sheilazilinsky.comPayPal https://www.paypal.com/paypalme/sheilazilinskyPatreon https://www.patreon.com/sheilazilinskyHOW TO LISTEN:BRAND NEW YOUTUBE CHANNEL https://www.youtube.com/@realsheilazRumble: https://rumble.com/user/RealSheilaZPodcast: https://www.podomatic.com/podcasts/sheilazilinskyApple Podcast: https://podcasts.apple.com/ca/podcast/the-sheila-zilinsky-show/id960689559FOLLOW SHEILA:Telegram: https://t.me/realsheilazTwitter: https://twitter.com/RealSheilaZFacebook: https://www.facebook.com/realSheilaZInstagram: https://www.instagram.com/sheilazilinskySubstack: https://sheilazilinsky.substack.com

Send me a DM here (it doesn't let me respond), OR email me: imagineabetterworld2020@gmail.comToday I'm honored to introduce you all to: Ritual Abuse, MK ULTRA, and organized abuse survivor, overcomer and thriver, content creator and podcast host of her own YouTube channel called “From PTSD to a Graduate Degree', artist and creative, scientific innovator and revolutionary, my new friend, and a woman pushing the boundaries on overcoming fear and trauma: Amy BergerBorn on January 3, 1977, in Whitestone, NY, Amy emerged from a childhood shadowed by profound adversity. Raised in a severely dysfunctional home, Amy endured a mother's untreated PTSD and level 5 hoarding, alongside a father's emotional abuse and crack addiction. From ages 9 to 18, she suffered molestation by her half-brother, leaving deep emotional wounds that fueled fear, self-harm, obsessive-compulsive behaviors, and teenage prostitution as a desperate survival mechanism. “I was not okay,” Amy reflects, her early years saturated with terror and devoid of tools to navigate it.1999, a seismic shift occurred. Amy began recovering suppressed memories of additional sexual abuse by family members and babysitters, followed by revelations of ritual abuse and MK ULTRA This turning point split her life into two: before memories and after. Through years of trauma therapy, she pieced together her psychological architecture, confronting paralyzing terror and periods of disability that left her reliant on social security.Yet Amy's story is one of relentless resilience. A few years ago, seeking distraction from fear, she returned to school - a decision that transformed her life. Now a senior Biology major at Worcester State University, Amy is poised to pursue a double master's in Biotechnology and Artificial Intelligence at WPI. Her ambition is laser-focused: to revolutionize synthetic biology by targeting the FAAH gene to eliminate the fear response at its genetic root. Inspired by the rare genetic mutation of Jo Cameron, who feels no pain or anxiety, Amy aims to rewrite the biochemical terms of terror, stripping away the leverage trauma and cult programming hold over survivors like herself.In her inspiring YouTube video series, From PTSD to a Graduate Degree, Amy shares her journey with raw honesty. “How do I do it?” she asks, detailing the scaffolding that supports her success: two trauma-specialized therapists, open communication with professors, healthy social connections, and a disciplined yet gentle study routine. Even on days when anxiety surges, Amy stays ahead, having only missed three classes in two years. Her scientific passion drives her to explore groundbreaking research, collaborating with AI to design a study on FAAH gene modulation to enhance fear extinction - a project she hopes to develop as a graduate thesis.Amy's vision is bold and personal: to create a world where no one feels the crippling fear she once did. Her journey from a shattered childhood to a pioneering scientist is a testament to the power of resilience, education, and an unwavering commitment to rewriting her story - and the future of human emotional experience. “I've come a tremendously long way,” she says on one of her YouTube videos, her voice a beacon of hope for others. With a groundbreaking study on FAAH gene modulation already taking shape, Amy isn't just healing herself - she's igniting a revolution, paving the way for a fearless future where every soul can find safety, stability, and boundless possibility - proving that even the deepest wounds can fuel extraordinary change.CONNECT WITH AMY: YouTube: @FromPTSDtoaGraduateDegree - Support the show

In this episode of the Fitness + Technology Podcast, host Bryan O'Rourke sits down with Jeff Zwiefel, Executive Director of Longevity & Performance at Life Time. With over three decades of leadership in the health, fitness, and wellness industry, Jeff brings a wealth of experience in strategic planning, brand evolution, and operational excellence. As a key architect behind Life Time's transformation into a comprehensive healthy lifestyle company, Jeff shares his perspective on the future of wellness, the role of leadership in culture and innovation, and strategies for advancing health span and performance.  Tune in for a powerful conversation filled with insights from one of the industry's most influential leaders. One Powerful Quote: 25:57: “We have two lives, and the second one begins when we realize we only have one.” 4-10 Bullet Points (w/ timestamps) - Highlighting key topics discussed: 2:04: Bryan opens the conversation with an overview of Jeff's extensive background and career journey. 4:33: The discussion turns to market bifurcation, as Bryan asks Jeff about evolving consumer demands and value delivery. Jeff explains how Life Time has strategically scaled to meet these shifting dynamics. 8:46: Bryan and Jeff explore the role of customer personas and how these insights influence alignment across the entire organization. 11:54: Jeff highlights emerging trends in health and wellness and shares how Life Time is innovating to meet these demands through enhanced service offerings. 17:00: The conversation delves into biotechnology and its growing influence on extending health span and optimizing performance. 20:16: Jeff discusses how Life Time maintains a strong cultural foundation while operating at scale, emphasizing the importance of human connection in large organizations. 24:37: Jeff concludes with key takeaways and lasting insights for listeners, offering wisdom from his decades of leadership in the industry. Bullet List of Resources: https://jeffzwiefel.com/ https://www.lifetime.life/ https://hbr.org/2008/07/putting-the-service-profit-chain-to-work Guest Contact Information: https://www.linkedin.com/in/jeffzwiefel/ https://x.com/JeffZwiefel https://www.bryankorourke.com/ https://www.linkedin.com/in/bryankorourke/ http://www.fittechcouncil.org/ https://www.youtube.com/user/bko61163

For episode 565 of the BlockHash Podcast, host Brandon Zemp is joined by Shahaf Bar-Geffen, CEO of COTI.Shahaf has been the CEO of COTI for more than four years now. He has also been part of the COTI founding team. He is known as the founder of WEB3, an online marketing group, as well as Positive Mobile, both of which were acquired. Shahaf studied Computer Science, Biotechnology and Economics in Tel-Aviv University. On top of that, he has had a long and impressive career in the Air Force. Learn more at https://www.coti.io ⏳ Timestamps: (0:00) Introduction(1:12) Who is Shahaf?(3:55) What is COTI?(8:34) What holds back adoption of blockchain?(10:23) How does COTI work?(12:54) Use-cases(16:32) Balancing Privacy with Compliance (20:33) COTI performance benchmarks(24:02) COTI roadmap in 2025(28:28) COTI website, socials & community 

Latt Mansor explores the multifaceted role of ketones, particularly their influence on brain health, fertility, memory, and focus. The re-release of an episode from 2023 delves into their impact on serotonin receptors, blood glucose regulation, and weight management. Mansor also highlights the potential therapeutic benefits of ketones for conditions such as sleep disturbances, infertility, depression, and Alzheimer's. If you want a balanced approach to health discussions, where scientific understanding encourages expanded knowledge and experience rather than limitations, this is the episode for you. To view full show notes, more information on our guests, resources mentioned in the episode, discount codes, transcripts, and more, visit https://drmindypelz.com/ep296 Dr. Latt Mansor holds a Ph.D. in Physiology, Anatomy and Genetics from the University of Oxford, where his research focused on the metabolism of type 2 diabetic heart in hypoxia. He also holds an M.A. (Columbia University) and a B.Sc. (Hons) (University of Nottingham) in Biotechnology. He is a world expert in physiology and metabolism and consults with elite sports, military, clinical and research organizations. Check out our fasting membership at resetacademy.drmindypelz.com. Please note our medical disclaimer.